Literature DB >> 28613398

Fetal and umbilical Doppler ultrasound in high-risk pregnancies.

Zarko Alfirevic1, Tamara Stampalija, Therese Dowswell.   

Abstract

BACKGROUND: Abnormal blood flow patterns in fetal circulation detected by Doppler ultrasound may indicate poor fetal prognosis. It is also possible that false positive Doppler ultrasound findings could lead to adverse outcomes from unnecessary interventions, including preterm delivery.
OBJECTIVES: The objective of this review was to assess the effects of Doppler ultrasound used to assess fetal well-being in high-risk pregnancies on obstetric care and fetal outcomes. SEARCH
METHODS: We updated the search of Cochrane Pregnancy and Childbirth's Trials Register on 31 March 2017 and checked reference lists of retrieved studies. SELECTION CRITERIA: Randomised and quasi-randomised controlled trials of Doppler ultrasound for the investigation of umbilical and fetal vessels waveforms in high-risk pregnancies compared with no Doppler ultrasound. Cluster-randomised trials were eligible for inclusion but none were identified. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed the studies for inclusion, assessed risk of bias and carried out data extraction. Data entry was checked. We assessed the quality of evidence using the GRADE approach. MAIN
RESULTS: Nineteen trials involving 10,667 women were included. Risk of bias in trials was difficult to assess accurately due to incomplete reporting. None of the evidence relating to our main outcomes was graded as high quality. The quality of evidence was downgraded due to missing information on trial methods, imprecision in risk estimates and heterogeneity. Eighteen of these studies compared the use of Doppler ultrasound of the umbilical artery of the unborn baby with no Doppler or with cardiotocography (CTG). One more recent trial compared Doppler examination of other fetal blood vessels (ductus venosus) with computerised CTG.The use of Doppler ultrasound of the umbilical artery in high-risk pregnancy was associated with fewer perinatal deaths (risk ratio (RR) 0.71, 95% confidence interval (CI) 0.52 to 0.98, 16 studies, 10,225 babies, 1.2% versus 1.7 %, number needed to treat (NNT) = 203; 95% CI 103 to 4352, evidence graded moderate). The results for stillbirths were consistent with the overall rate of perinatal deaths, although there was no clear difference between groups for this outcome (RR 0.65, 95% CI 0.41 to 1.04; 15 studies, 9560 babies, evidence graded low). Where Doppler ultrasound was used, there were fewer inductions of labour (average RR 0.89, 95% CI 0.80 to 0.99, 10 studies, 5633 women, random-effects, evidence graded moderate) and fewer caesarean sections (RR 0.90, 95% CI 0.84 to 0.97, 14 studies, 7918 women, evidence graded moderate). There was no comparative long-term follow-up of babies exposed to Doppler ultrasound in pregnancy in women at increased risk of complications.No difference was found in operative vaginal births (RR 0.95, 95% CI 0.80 to 1.14, four studies, 2813 women), nor in Apgar scores less than seven at five minutes (RR 0.92, 95% CI 0.69 to 1.24, seven studies, 6321 babies, evidence graded low). Data for serious neonatal morbidity were not pooled due to high heterogeneity between the three studies that reported it (1098 babies) (evidence graded very low).The use of Doppler to evaluate early and late changes in ductus venosus in early fetal growth restriction was not associated with significant differences in any perinatal death after randomisation. However, there was an improvement in long-term neurological outcome in the cohort of babies in whom the trigger for delivery was either late changes in ductus venosus or abnormalities seen on computerised CTG. AUTHORS'
CONCLUSIONS: Current evidence suggests that the use of Doppler ultrasound on the umbilical artery in high-risk pregnancies reduces the risk of perinatal deaths and may result in fewer obstetric interventions. The results should be interpreted with caution, as the evidence is not of high quality. Serial monitoring of Doppler changes in ductus venosus may be beneficial, but more studies of high quality with follow-up including neurological development are needed for evidence to be conclusive.

Entities:  

Mesh:

Year:  2017        PMID: 28613398      PMCID: PMC6481396          DOI: 10.1002/14651858.CD007529.pub4

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  66 in total

1.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.

Authors:  D Moher; K F Schulz; D G Altman
Journal:  Lancet       Date:  2001-04-14       Impact factor: 79.321

Review 2.  Doppler ultrasound for fetal assessment in high risk pregnancies.

Authors:  J P Neilson; Z Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2000

3.  Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network.

Authors:  I M Bernstein; J D Horbar; G J Badger; A Ohlsson; A Golan
Journal:  Am J Obstet Gynecol       Date:  2000-01       Impact factor: 8.661

4.  The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens.

Authors:  A A Baschat; U Gembruch; C R Harman
Journal:  Ultrasound Obstet Gynecol       Date:  2001-12       Impact factor: 7.299

5.  Monitoring of fetuses with intrauterine growth restriction: a longitudinal study.

Authors:  K Hecher; C M Bilardo; R H Stigter; Y Ville; B J Hackelöer; H J Kok; M V Senat; G H Visser
Journal:  Ultrasound Obstet Gynecol       Date:  2001-12       Impact factor: 7.299

6.  A critical appraisal of the use of umbilical artery Doppler ultrasound in high-risk pregnancies: use of meta-analyses in evidence-based obstetrics.

Authors:  H B Westergaard; J Langhoff-Roos; G Lingman; K Marsál; S Kreiner
Journal:  Ultrasound Obstet Gynecol       Date:  2001-06       Impact factor: 7.299

Review 7.  Evaluation of the fetal coronary circulation.

Authors:  A A Baschat; U Gembruch
Journal:  Ultrasound Obstet Gynecol       Date:  2002-10       Impact factor: 7.299

Review 8.  How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review.

Authors:  Zarko Alfirevic; Devender Roberts; Vanessa Martlew
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2002-02-10       Impact factor: 2.435

Review 9.  Thrombosis in pregnancy: maternal and fetal issues.

Authors:  I A Greer
Journal:  Lancet       Date:  1999-04-10       Impact factor: 79.321

10.  Temporal sequence of abnormal Doppler changes in the peripheral and central circulatory systems of the severely growth-restricted fetus.

Authors:  E Ferrazzi; M Bozzo; S Rigano; M Bellotti; A Morabito; G Pardi; F C Battaglia; H L Galan
Journal:  Ultrasound Obstet Gynecol       Date:  2002-02       Impact factor: 7.299

View more
  48 in total

1.  Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis.

Authors:  Gordon Cs Smith; Alexandros A Moraitis; David Wastlund; Jim G Thornton; Aris Papageorghiou; Julia Sanders; Alexander Ep Heazell; Stephen C Robson; Ulla Sovio; Peter Brocklehurst; Edward Cf Wilson
Journal:  Health Technol Assess       Date:  2021-02       Impact factor: 4.014

Review 2.  Optimal Obstetric Management for Women with Diabetes: the Benefits and Costs of Fetal Surveillance.

Authors:  Ukachi N Emeruwa; Chloe Zera
Journal:  Curr Diab Rep       Date:  2018-09-07       Impact factor: 4.810

3.  Overexpression of the aryl hydrocarbon receptor nuclear translocator partially rescues fetoplacental angiogenesis in severe fetal growth restriction.

Authors:  Shuhan Ji; Hong Xin; Emily J Su
Journal:  Clin Sci (Lond)       Date:  2019-06-20       Impact factor: 6.124

4.  Exploring in vivo placental microstructure in healthy and growth-restricted pregnancies through diffusion-weighted magnetic resonance imaging.

Authors:  Nickie Andescavage; Wonsang You; Marni Jacobs; Kushal Kapse; Jessica Quistorff; Dorothy Bulas; Homa Ahmadzia; Alexis Gimovsky; Ahmet Baschat; Catherine Limperopoulos
Journal:  Placenta       Date:  2020-03-06       Impact factor: 3.481

Review 5.  Molecular and cellular underpinnings of normal and abnormal human placental blood flows.

Authors:  Yingchun Li; Ramón A Lorca; Emily J Su
Journal:  J Mol Endocrinol       Date:  2017-11-02       Impact factor: 5.098

6.  A systematic scoping review to identify the design and assess the performance of devices for antenatal continuous fetal monitoring.

Authors:  Kajal K Tamber; Dexter J L Hayes; Stephen J Carey; Jayawan H B Wijekoon; Alexander E P Heazell
Journal:  PLoS One       Date:  2020-12-01       Impact factor: 3.240

7.  Prediction of adverse perinatal outcome by fetal biometry: comparison of customized and population-based standards.

Authors:  D Kabiri; R Romero; D W Gudicha; E Hernandez-Andrade; P Pacora; N Benshalom-Tirosh; D Tirosh; L Yeo; O Erez; S S Hassan; A L Tarca
Journal:  Ultrasound Obstet Gynecol       Date:  2020-02       Impact factor: 7.299

8.  Efficient differentiation of vascular smooth muscle cells from Wharton's Jelly mesenchymal stromal cells using human platelet lysate: A potential cell source for small blood vessel engineering.

Authors:  Panagiotis Mallis; Aggeliki Papapanagiotou; Michalis Katsimpoulas; Alkiviadis Kostakis; Gerasimos Siasos; Eva Kassi; Catherine Stavropoulos-Giokas; Efstathios Michalopoulos
Journal:  World J Stem Cells       Date:  2020-03-26       Impact factor: 5.326

Review 9.  Exercise in Pregnant Women with Diabetes.

Authors:  Tricia M Peters; Anne-Sophie Brazeau
Journal:  Curr Diab Rep       Date:  2019-08-06       Impact factor: 4.810

10.  The role and mechanism of asymmetric dimethylarginine in fetal growth restriction via interference with endothelial function and angiogenesis.

Authors:  Yan Dai; Jun Zhang; Rong Liu; Na Xu; Song-Biao Yan; Yi Chen; Tian-He Li
Journal:  J Assist Reprod Genet       Date:  2020-03-25       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.